Dr. Jessica Rose, a viral immunologist, presented data to the FDA showing a massive spike in adverse event reports in the VAERS database for 2021 compared to the previous ten years. Additionally, testimony from an early treatment center CEO claimed that Pfizer's six-month trial report showed more heart attacks in the treatment group than the placebo group, suggesting a negative net all-cause mortality.
